The Road from Nanomedicine to Precision Medicine
Part B
- 600 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
The Road from Nanomedicine to Precision Medicine
Part B
About This Book
The enormous advances in nanomedicine and precision medicine in the past two decades necessitated this comprehensive reference, which can be relied upon by researchers, clinicians, pharmaceutical scientists, regulators, policymakers, and lawyers alike. This standalone, full-color resource broadly surveys innovative technologies and advances pertaining to nanomedicine and precision medicine. In addition, it addresses often-neglected yet crucial areas such as translational medicine, intellectual property law, ethics, policy, FDA regulatory issues, nano-nomenclature, and artificial nano-machinesâall accomplished in a user-friendly, broad yet interconnected format. The book is essential reading for the novice and the expert alike in diverse fields such as medicine, law, pharmacy, genomics, biomedical sciences, ethics, and regulatory science. The book's multidisciplinary approach will attract a global audience and serve as a valuable reference resource for industry, academia, and government.
Frequently asked questions
Information
Table of contents
- Cover
- Half Title
- Series Page
- Title Page
- Copyright Page
- Dedication
- Cover Image
- American Society For Nanomedicine
- CLINAM
- About the Editors
- Table of Contents
- List of Corresponding Authors
- Preface
- 18. Proteomic Profiling and Predictive Biomarkers in Neuro-Traumatology and Neuro-Oncology
- 19. Nanomedicine and Personalized Care: Facts and Fiction
- 20. Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
- 21. Developing a Case-Based Blended Learning Ecosystem to Optimize Precision Medicine: Reducing Overdiagnosis and Overtreatment
- 22. Views from the FDA: Precision Medicine, Genetic Variant Databases and Companion Diagnostics
- 23. Protein-Based Nanoparticle Materials for Medical Applications
- 24. Nanomedicine and Phage Capsids
- 25. Pharmacogenomics: Ethical, Social, and Public Policy Issues
- 26. From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology
- 27. Harmonizing Outcomes for Genomic Medicine: Comparison of eMERGE Outcomes to ClinGen Outcome/Intervention Pairs
- 28. Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
- 29. Precision or Personalized Medicine for Cancer Chemotherapy: Is There a Role for Herbal Medicine?
- 30. Personomics: The Missing Link in the Evolution from Precision Medicine to Personalized Medicine
- 31. Stem Cell Banking for Regenerative and Personalized Medicine
- 32. Overview of Ethical Issues in Nanomedicine
- 33. Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders
- 34. Peptide-Based Drug Delivery Systems: Future Challenges, Perspectives, and Opportunities in Nanomedicine
- 35. Hydrogels and Their Applications in Targeted Drug Delivery
- 36. Emergence of Real World Evidence in Precision Medicine
- Index